| Stem Cell Transplant |
27.3% |
| Adult T-cell Lymphoma/leukaemia |
14.6% |
| Multiple Myeloma |
8.8% |
| Non-hodgkin's Lymphoma |
7.5% |
| Immunosuppression |
6.5% |
| Allogenic Bone Marrow Transplantation Therapy |
3.9% |
| Bone Lesion |
3.9% |
| Chronic Myeloid Leukaemia |
3.6% |
| Immunosuppressant Drug Therapy |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Prophylaxis |
2.9% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.9% |
| Hypertension |
1.9% |
| Diffuse Large B-cell Lymphoma Stage Ii |
1.6% |
| Glioblastoma Multiforme |
1.6% |
| Pharyngitis |
1.6% |
| Bronchitis |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Fluid Retention |
1.3% |
